ArticleDiabetology & metabolic syndrome2020

Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus.

Dong-Ni Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.